Bill > HB4065

This bill establishes the 340B Grantee Contract Pharmacy Access Act, which aims to protect the rights of 340B grantees and their contract pharmacies in acquiring discounted drugs. The 340B program is a federal initiative that allows certain healthcare organizations (like community health centers, hospitals serving low-income populations, and some specialized clinics) to purchase outpatient drugs at reduced prices. The bill defines key terms such as 340B grantees (healthcare entities qualifying under federal guidelines), 340B contract pharmacies (pharmacies contracted to dispense these discounted drugs), and 340B drugs (medications subject to reduced pricing). Specifically, the bill prohibits any person, including pharmaceutical manufacturers, from denying, restricting, or limiting the acquisition of 340B drugs by qualified grantees or their contract pharmacies, unless such acquisition is prohibited by federal law. The Department of Financial and Professional Regulation is authorized to enforce the act and investigate potential violations. The bill includes preemption provisions ensuring that it cannot conflict with federal law or be less restrictive than existing regulations, and it takes effect immediately upon becoming law. The legislation ultimately seeks to ensure that eligible healthcare providers can access discounted medications through their chosen pharmacies without undue restrictions.

https://www.ilga.gov/legislation/BillStatus.asp?DocNum=4065&GAID=18&DocTypeID=HB&SessionID=114&GA=104